Survey and questionnaire on the increase of dental insurance coverage of analgesic agents.
スポンサーリンク
概要
- 論文の詳細を見る
The primary analgesic agents used in dental practice (diclofenac sodium and loxoprofen sodium) currently are not covered by national health insurance for the indication of toothache.<BR>We conducted a survey of dentists from 11 national university dental hospitals using a short questionnaire to determine their perceptions regarding the need for insurance coverage for dental therapeutics. In total, 132 questionnaires were returned, and approximately 22.5% of the dentists noted that they routinely order diclofenac and loxoprofen to treat toothache despite knowing that such use is considered off-label and thereby not covered by insurance.<BR>To increase insurance coverage for dental medications, medical and dental scientific organizations should convince health agencies to pressure pharmaceutical manufacturers to conduct clinical trials and seek regulatory approval for unlabeled dental indications.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果